IE54119B1 - Pharmaceutical formulations comprising human insulin and human c-peptide - Google Patents
Pharmaceutical formulations comprising human insulin and human c-peptideInfo
- Publication number
- IE54119B1 IE54119B1 IE2064/82A IE206482A IE54119B1 IE 54119 B1 IE54119 B1 IE 54119B1 IE 2064/82 A IE2064/82 A IE 2064/82A IE 206482 A IE206482 A IE 206482A IE 54119 B1 IE54119 B1 IE 54119B1
- Authority
- IE
- Ireland
- Prior art keywords
- human
- insulin
- peptide
- human insulin
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29671581A | 1981-08-27 | 1981-08-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE822064L IE822064L (en) | 1983-02-27 |
| IE54119B1 true IE54119B1 (en) | 1989-06-21 |
Family
ID=23143238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2064/82A IE54119B1 (en) | 1981-08-27 | 1982-08-26 | Pharmaceutical formulations comprising human insulin and human c-peptide |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS5846024A (it) |
| AU (1) | AU551879B2 (it) |
| BE (1) | BE894185A (it) |
| CA (1) | CA1176158A (it) |
| CH (1) | CH650679A5 (it) |
| DE (1) | DE3232034A1 (it) |
| DZ (1) | DZ452A1 (it) |
| FR (1) | FR2513126B1 (it) |
| GB (1) | GB2104382B (it) |
| IE (1) | IE54119B1 (it) |
| IL (1) | IL66611A0 (it) |
| IT (1) | IT1153182B (it) |
| LU (1) | LU84359A1 (it) |
| MW (1) | MW3882A1 (it) |
| NL (1) | NL192192C (it) |
| NZ (1) | NZ201682A (it) |
| PH (1) | PH19361A (it) |
| SE (1) | SE460334B (it) |
| ZA (1) | ZA826159B (it) |
| ZW (1) | ZW17482A1 (it) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| CA1296253C (en) * | 1986-10-20 | 1992-02-25 | Praveen Tyle | Stabilized growth hormone compositions |
| WO1988002633A1 (en) * | 1986-10-20 | 1988-04-21 | Novo Industri A/S | Protamine zinc insulin preparations |
| EP0280534B1 (en) * | 1987-02-25 | 1993-04-21 | Novo Nordisk A/S | Novel insulin derivatives |
| US5212154A (en) * | 1987-08-14 | 1993-05-18 | Akzo N.V. | Preparation for treating complications in diabetes |
| EP0303308B1 (en) * | 1987-08-14 | 1991-05-29 | Akzo N.V. | Preparation for preventing or combating complications in diabetes |
| SE520392C2 (sv) | 1996-09-27 | 2003-07-01 | Creative Peptides Sweden Ab C | Specifika peptider för behandling av diabetes mellitus |
| GB0323979D0 (en) | 2003-10-13 | 2003-11-19 | Creative Peptides Sweden Ab | Therapeutic applications for c-peptide |
| US8263551B2 (en) | 2004-11-22 | 2012-09-11 | Novo Nordisk A/S | Soluble, stable insulin-containing formulations with a protamine salt |
| GB0511269D0 (en) | 2005-06-02 | 2005-07-13 | Creative Peptides Sweden Ab | Sustained release preparation of pro-insulin C-peptide |
| GB0601950D0 (en) * | 2006-01-31 | 2006-03-15 | Creative Peptides Sweden Ab | Compositions and methods of treating diabetes |
| JP5765813B2 (ja) | 2008-09-19 | 2015-08-19 | ウェルズ ファーゴ バンク ナショナル アソシエイション | 治療用ペプチドのポリマーコンジュゲート |
| WO2011146518A2 (en) | 2010-05-17 | 2011-11-24 | Cebix Inc. | Pegylated c-peptide |
| CN104220086A (zh) | 2011-11-17 | 2014-12-17 | 塞比克斯股份公司 | Peg化的c-肽 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789080A (en) * | 1952-08-14 | 1957-04-16 | Christensen Henry Marinus | Insulin-albumin compositions |
| CH330318A (de) * | 1953-09-08 | 1958-05-31 | British Drug Houses Ltd | Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit |
-
1982
- 1982-08-23 ZW ZW174/82A patent/ZW17482A1/xx unknown
- 1982-08-23 CH CH5010/82A patent/CH650679A5/de not_active IP Right Cessation
- 1982-08-23 CA CA000409900A patent/CA1176158A/en not_active Expired
- 1982-08-23 IL IL66611A patent/IL66611A0/xx unknown
- 1982-08-24 ZA ZA826159A patent/ZA826159B/xx unknown
- 1982-08-24 DZ DZ826637A patent/DZ452A1/fr active
- 1982-08-24 MW MW38/82A patent/MW3882A1/xx unknown
- 1982-08-24 NZ NZ201682A patent/NZ201682A/en unknown
- 1982-08-24 BE BE6/47701A patent/BE894185A/fr not_active IP Right Cessation
- 1982-08-24 NL NL8203315A patent/NL192192C/nl not_active IP Right Cessation
- 1982-08-24 PH PH27772A patent/PH19361A/en unknown
- 1982-08-25 SE SE8204873A patent/SE460334B/sv not_active IP Right Cessation
- 1982-08-25 FR FR8214595A patent/FR2513126B1/fr not_active Expired
- 1982-08-25 JP JP57148494A patent/JPS5846024A/ja active Pending
- 1982-08-25 AU AU87594/82A patent/AU551879B2/en not_active Expired
- 1982-08-26 LU LU84359A patent/LU84359A1/fr unknown
- 1982-08-26 GB GB08224484A patent/GB2104382B/en not_active Expired
- 1982-08-26 IE IE2064/82A patent/IE54119B1/en not_active IP Right Cessation
- 1982-08-27 DE DE19823232034 patent/DE3232034A1/de active Granted
- 1982-08-27 IT IT8223017A patent/IT1153182B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| CH650679A5 (de) | 1985-08-15 |
| SE460334B (sv) | 1989-10-02 |
| FR2513126A1 (fr) | 1983-03-25 |
| NZ201682A (en) | 1985-08-16 |
| NL192192C (nl) | 1997-03-04 |
| GB2104382B (en) | 1984-12-19 |
| JPS5846024A (ja) | 1983-03-17 |
| MW3882A1 (en) | 1984-07-11 |
| IT8223017A0 (it) | 1982-08-27 |
| DE3232034C2 (it) | 1991-04-11 |
| SE8204873L (sv) | 1983-02-28 |
| NL192192B (nl) | 1996-11-01 |
| AU8759482A (en) | 1983-03-03 |
| CA1176158A (en) | 1984-10-16 |
| IE822064L (en) | 1983-02-27 |
| DZ452A1 (fr) | 2004-09-13 |
| AU551879B2 (en) | 1986-05-15 |
| IT1153182B (it) | 1987-01-14 |
| DE3232034A1 (de) | 1983-03-10 |
| ZW17482A1 (en) | 1982-11-17 |
| LU84359A1 (fr) | 1983-02-28 |
| ZA826159B (en) | 1984-04-25 |
| GB2104382A (en) | 1983-03-09 |
| SE8204873D0 (sv) | 1982-08-25 |
| FR2513126B1 (fr) | 1986-04-18 |
| PH19361A (en) | 1986-04-02 |
| BE894185A (fr) | 1983-02-24 |
| NL8203315A (nl) | 1983-03-16 |
| IL66611A0 (en) | 1982-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100546225B1 (ko) | 신속한 작용개시를 나타내는 인슐린 유도체 | |
| CA1176161A (en) | Pharmaceutical formulations comprising human insulin and human proinsulin | |
| US6136784A (en) | Amylin agonist pharmaceutical compositions containing insulin | |
| KR100386038B1 (ko) | 단량체성인슐린유사체의제제 | |
| CA1176158A (en) | Pharmaceutical formulations comprising human insulin and human c-peptide | |
| US4652548A (en) | Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin | |
| EP0490955B1 (en) | Treatment of insulin-resistant diabetes | |
| JPWO2004037859A1 (ja) | Ｇｌｐ−１誘導体及びその経粘膜吸収型製剤 | |
| NO178914B (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat for behandling av Diabetes mellitus | |
| EP0613376B1 (en) | Use of igf-1 | |
| CA2527039C (en) | Grf analog compositions and their use | |
| US4654324A (en) | Human proinsulin pharmaceutical formulations | |
| JP4726797B2 (ja) | 消耗症に罹患している患者の治療における成長ホルモン放出因子類似体の使用 | |
| JP4402296B2 (ja) | 亜鉛結合性が増大された新規なインスリン同族体 | |
| CA1176160A (en) | Human proinsulin pharmaceutical formulations | |
| CA1176159A (en) | Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin | |
| AU2004283526A1 (en) | Therapeutic applications for C-peptide | |
| AU5916298A (en) | Amylin agonist pharmaceutical compositions containing insulin | |
| CA2237643C (en) | Therapeutic agent for acute hepatic failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK9A | Patent expired |